266 related articles for article (PubMed ID: 24832560)
1. Cefpodoxime for antimicrobial prophylaxis in neutropenia: a retrospective case series.
Wojenski DJ; Barreto JN; Wolf RC; Tosh PK
Clin Ther; 2014 Jun; 36(6):976-81. PubMed ID: 24832560
[TBL] [Abstract][Full Text] [Related]
2. A comparison of levofloxacin and oral third-generation cephalosporins as antibacterial prophylaxis in acute leukaemia patients during chemotherapy-induced neutropenia.
Yemm KE; Barreto JN; Mara KC; Dierkhising RA; Gangat N; Tosh PK
J Antimicrob Chemother; 2018 Jan; 73(1):204-211. PubMed ID: 29040595
[TBL] [Abstract][Full Text] [Related]
3. Comparison of antibiotic prophylaxis with cotrimoxazole/colistin (COT/COL) versus ciprofloxacin (CIP) in patients with acute myeloid leukemia.
Mayer K; Hahn-Ast C; Mückter S; Schmitz A; Krause S; Felder L; Bekeredjian-Ding I; Molitor E; Brossart P; von Lilienfeld-Toal M
Support Care Cancer; 2015 May; 23(5):1321-9. PubMed ID: 25617073
[TBL] [Abstract][Full Text] [Related]
4. Levofloxacin versus Cefpodoxime for Antibacterial Prophylaxis in Allogeneic Stem Cell Transplantation.
Doan VP; Yeh JC; Gulbis AM; Aitken SL; Ariza-Heredia E; Ahmed S
Biol Blood Marrow Transplant; 2019 Aug; 25(8):1637-1641. PubMed ID: 31002991
[TBL] [Abstract][Full Text] [Related]
5. Use of antibacterial prophylaxis for patients with neutropenia. Australian Consensus Guidelines 2011 Steering Committee.
Slavin MA; Lingaratnam S; Mileshkin L; Booth DL; Cain MJ; Ritchie DS; Wei A; Thursky KA;
Intern Med J; 2011 Jan; 41(1b):102-9. PubMed ID: 21272174
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology clinical practice guideline.
Flowers CR; Seidenfeld J; Bow EJ; Karten C; Gleason C; Hawley DK; Kuderer NM; Langston AA; Marr KA; Rolston KV; Ramsey SD
J Clin Oncol; 2013 Feb; 31(6):794-810. PubMed ID: 23319691
[TBL] [Abstract][Full Text] [Related]
7. Impact of fluoroquinolone prophylaxis on reduced infection-related mortality among patients with neutropenia and hematologic malignancies.
Reuter S; Kern WV; Sigge A; Döhner H; Marre R; Kern P; von Baum H
Clin Infect Dis; 2005 Apr; 40(8):1087-93. PubMed ID: 15791505
[TBL] [Abstract][Full Text] [Related]
8. Utility of fosfomycin as antibacterial prophylaxis in patients with hematologic malignancies.
Zapolskaya T; Perreault S; McManus D; Topal JE
Support Care Cancer; 2018 Jun; 26(6):1979-1983. PubMed ID: 29322242
[TBL] [Abstract][Full Text] [Related]
9. A single-center evaluation of the risk for colonization or bacteremia with piperacillin-tazobactam- and cefepime-resistant bacteria in patients with acute leukemia receiving fluoroquinolone prophylaxis.
Nguyen AD; Heil EL; Patel NK; Duffy A; Gilmore S
J Oncol Pharm Pract; 2016 Apr; 22(2):303-7. PubMed ID: 25567517
[TBL] [Abstract][Full Text] [Related]
10. [Fluoroquinolones to prevent bacterial infection in children with chemotherapy induced neutropenia: is it reasonable?].
Dubos F; Delebarre M; Lagrée M
Arch Pediatr; 2013 Nov; 20 Suppl 3():S90-3. PubMed ID: 24360309
[TBL] [Abstract][Full Text] [Related]
11. Clinical and microbiological impact of discontinuation of fluoroquinolone prophylaxis in patients with prolonged profound neutropenia.
Verlinden A; Jansens H; Goossens H; van de Velde AL; Schroyens WA; Berneman ZN; Gadisseur AP
Eur J Haematol; 2014 Oct; 93(4):302-8. PubMed ID: 24750350
[TBL] [Abstract][Full Text] [Related]
12. Effect of discontinuing prophylaxis with norfloxacin in patients with hematologic malignancies and severe neutropenia. A matched case-control study of the effect on infectious morbidity.
Martino R; Subira M; Altés A; López R; Sureda A; Domingo-Albós A; Pericas R; Brunet S
Acta Haematol; 1998; 99(4):206-11. PubMed ID: 9644298
[TBL] [Abstract][Full Text] [Related]
13. Third generation cephalosporin resistant Enterobacteriaceae and multidrug resistant gram-negative bacteria causing bacteremia in febrile neutropenia adult cancer patients in Lebanon, broad spectrum antibiotics use as a major risk factor, and correlation with poor prognosis.
Moghnieh R; Estaitieh N; Mugharbil A; Jisr T; Abdallah DI; Ziade F; Sinno L; Ibrahim A
Front Cell Infect Microbiol; 2015; 5():11. PubMed ID: 25729741
[TBL] [Abstract][Full Text] [Related]
14. [Clinical study on fluoroquinolone prophylaxis in neutropenia patients with acute leukemia].
Qin TJ; Mi YC; Feng SZ; Li DP; Wei JL; Yang DL; Han MZ; Wang JX; Bian SG
Zhonghua Yi Xue Za Zhi; 2007 May; 87(20):1389-93. PubMed ID: 17785058
[TBL] [Abstract][Full Text] [Related]
15. Safe fluoroquinolones prophylaxis in blood cancer patients with chemotherapy-induced neutropenia and Glucose-6-Phosphate-Dehydrogenase deficiency.
Sanna M; Caocci G; Orrù F; Ledda A; Vacca A; Piras E; Fozza C; Deias P; Tidore G; Dore F; La Nasa G
J Clin Pharm Ther; 2017 Dec; 42(6):733-737. PubMed ID: 28597476
[TBL] [Abstract][Full Text] [Related]
16. Antibiotic prophylaxis in chemotherapy-induced neutropenia: time to reconsider.
Lo N; Cullen M
Hematol Oncol; 2006 Sep; 24(3):120-5. PubMed ID: 16783844
[TBL] [Abstract][Full Text] [Related]
17. Meta-analysis: antibiotic prophylaxis reduces mortality in neutropenic patients.
Gafter-Gvili A; Fraser A; Paul M; Leibovici L
Ann Intern Med; 2005 Jun; 142(12 Pt 1):979-95. PubMed ID: 15968013
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of antibiotic prophylaxis in neutropenic patients with hematologic malignancies].
Delarive P; Baumgartner JD; Glauser MP; Cometta A
Schweiz Med Wochenschr; 2000 Dec; 130(48):1837-44. PubMed ID: 11132527
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Complication Rates with Antibiotic Prophylaxis with Cefpodoxime Versus Fluoroquinolones After Transrectal Prostate Biopsy.
Wenzel M; Welte MN; Theissen LH; Wittler C; Hoeh B; Humke C; Preisser F; Würnschimmel C; Tilki D; Graefen M; Roos FC; Becker A; Karakiewicz PI; Chun FKH; Kluth LA; Mandel P
Eur Urol Focus; 2021 Sep; 7(5):980-986. PubMed ID: 33358884
[TBL] [Abstract][Full Text] [Related]
20. Fluoroquinolones, antimicrobial resistance and neutropenic cancer patients.
Bow EJ
Curr Opin Infect Dis; 2011 Dec; 24(6):545-53. PubMed ID: 22001945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
